(Q37678989)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

1 reference

title

The effect of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Farhana Haseen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Liam J Murray

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Joe M O'Sullivan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Marie M Cantwell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

21 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091248%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Survivorship

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

128-139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091248%20AND%20SRC:MED&resulttype=core&format=json

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

17 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11764-009-0114-1

Routine protein energy supplementation in adults: systematic review

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11764-009-0114-1

Hormonal regulation of appetite and body mass in patients with advanced prostate cancer treated with combined androgen blockade

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11764-009-0114-1

Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinoma.

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

The influence of androgen deprivation therapy on metabolism in patients with prostate cancer

1 reference

12 December 2020

Insulin sensitivity during combined androgen blockade for prostate cancer

1 reference

12 December 2020

Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years

1 reference

12 December 2020

The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer

1 reference

12 December 2020

Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program

1 reference

12 December 2020

A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer

1 reference

12 December 2020

Treatment of prostate cancer with gonadotropin-releasing hormone analogue: effect on lipoprotein[a].

1 reference

12 December 2020

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

12 December 2020

Fatigue in patients with prostate cancer receiving hormone therapy.

1 reference

12 December 2020

Testosterone, body composition and aging

1 reference

12 December 2020

Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy

1 reference

12 December 2020

High-intensity strength training in nonagenarians. Effects on skeletal muscle

1 reference

12 December 2020

Effects of androgen suppression by gonadotropin-releasing hormone agonist and flutamide on lipid metabolism in men with prostate cancer: focus on lipoprotein(a)

1 reference

12 December 2020

Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men

1 reference

12 December 2020

Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality

1 reference

12 December 2020

Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31.

1 reference

12 December 2020

Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study.

1 reference

12 December 2020

Testosterone and behavior

1 reference

12 December 2020

The effect of 6 months of androgen deprivation therapy on muscle and fat mass in older men with localized prostate cancer.

1 reference

12 December 2020

Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma

1 reference

12 December 2020

Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists

1 reference

12 December 2020

Sarcopenia--exercise as a treatment strategy.

1 reference

12 December 2020

Endocrine profiles during administration of the new non‐steroidal anti‐androgen Casodex in prostate cancer

1 reference

12 December 2020

Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup

1 reference

12 December 2020

American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer

1 reference

12 December 2020

Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition

1 reference

12 December 2020

Body composition changes during androgen deprivation therapy for prostate cancer: a 2-year prospective study

1 reference

12 December 2020

Resistance Exercise in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

1 reference

12 December 2020

Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

1 reference

12 December 2020

Long-term effects of androgen deprivation therapy in prostate cancer patients

1 reference

12 December 2020

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

12 December 2020

Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004.

1 reference

12 December 2020

Benefits of a physical activity intervention for men with prostate cancer

1 reference

12 December 2020

Optimal hormonal therapy for advanced prostatic carcinoma.

1 reference

12 December 2020

Multi-component body composition models: recent advances and future directions

1 reference

12 December 2020

Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.

1 reference

12 December 2020

Nutritional and metabolic effects of gonadotropin-releasing hormone agonist treatment for prostate cancer

1 reference

12 December 2020

Diagnosis, management and screening of early localised prostate cancer.

1 reference

12 December 2020

Risk of fracture after androgen deprivation for prostate cancer

1 reference

12 December 2020

Leg extensor power and functional performance in very old men and women

1 reference

12 December 2020

Health implications of obesity: an NIH Consensus Development Conference

1 reference

12 December 2020

Estimating the mean and variance from the median, range, and the size of a sample

1 reference

12 December 2020

Changes in body composition during androgen deprivation therapy for prostate cancer

1 reference

12 December 2020

Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer Programme

1 reference

12 December 2020

Bicalutamide 150 mg maintains bone mineral density during monotherapy for localized or locally advanced prostate cancer

1 reference

12 December 2020

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

12 December 2020

Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer

1 reference

12 December 2020

Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age

1 reference

12 December 2020

Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome

1 reference

12 December 2020

Resistance Training and Reduction of Treatment Side Effects in Prostate Cancer Patients

1 reference

12 December 2020

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

12 December 2020

Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy.

1 reference

12 December 2020

10.1007/S11764-009-0114-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference